Mirum Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 6.57 M | $256.25 M | 1.15% | 13.75% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 4.48 M | $174.74 M | -10.19% | 9.38% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 3.45 M | $134.37 M | -4.69% | 7.21% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.37 M | $131.36 M | 100.00% | 7.05% |
| BVF INC/IL | 11/14/2024 | 3.08 M | $119.96 M | -29.61% | 6.44% |
| VANGUARD GROUP INC | 11/13/2024 | 2.50 M | $97.35 M | 2.02% | 5.22% |
| STATE STREET CORP | 11/14/2024 | 1.79 M | $69.96 M | 19.88% | 3.75% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.58 M | $61.64 M | -10.81% | 3.31% |
| NOVO HOLDINGS A/S | 10/24/2024 | 1.50 M | $58.50 M | 0.00% | 3.14% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.39 M | $54.26 M | -12.25% | 2.91% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.29 M | $50.20 M | 0.00% | 2.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.28 M | $50.08 M | 7.08% | 2.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 936,197 | $36.52 M | 3.20% | 1.96% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 895,690 | $34.93 M | 2.35% | 1.87% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 889,100 | $34.67 M | 27.03% | 1.86% |
| LORD, ABBETT & CO. LLC | 12/13/2024 | 741,368 | $28.91 M | 100.00% | 1.55% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 731,104 | $28.51 M | 0.00% | 1.53% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 675,000 | $26.33 M | -8.91% | 1.41% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 647,611 | $25.26 M | -7.93% | 1.36% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 637,967 | $24.88 M | -15.95% | 1.34% |
| MORGAN STANLEY | 11/14/2024 | 625,916 | $24.41 M | 15.69% | 1.31% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 592,656 | $23.57 M | -37.06% | 1.24% |
| BOONE CAPITAL MANAGEMENT LLC | 11/14/2024 | 543,843 | $21.21 M | 3.85% | 1.14% |
| CANDRIAM S.C.A. | 11/13/2024 | 508,475 | $19.83 M | 0.00% | 1.06% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 499,316 | $19.47 M | 100.00% | 1.05% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 492,723 | $19.22 M | 0.03% | 1.03% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 492,409 | $19.20 M | 20.95% | 1.03% |
| CADIAN CAPITAL MANAGEMENT, LP | 11/14/2024 | 475,714 | $18.55 M | -61.48% | 1.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 466,209 | $18.18 M | 40.38% | 0.98% |
| PROSIGHT MANAGEMENT, LP | 11/14/2024 | 465,825 | $18.17 M | 47.97% | 0.97% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 455,564 | $17.77 M | 71.62% | 0.95% |
| AXA S.A. | 11/14/2024 | 426,068 | $16.62 M | 0.02% | 0.89% |
| WOODLINE PARTNERS LP | 11/14/2024 | 331,005 | $12.91 M | 62.48% | 0.69% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 328,161 | $12.80 M | 5.51% | 0.69% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 11/14/2024 | 309,244 | $12.09 M | 28.24% | 0.65% |
| INVESCO LTD. | 11/12/2024 | 284,532 | $11.10 M | 0.17% | 0.60% |
| 11/14/2024 | 260,000 | $10.14 B | 0.00% | 0.54% | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 256,779 | $10.01 M | 100.00% | 0.54% |
| BARCLAYS PLC | 11/19/2024 | 245,918 | $9.59 M | 4.60% | 0.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 242,711 | $9.47 M | 5.65% | 0.51% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 228,351 | $8.91 M | 20.11% | 0.48% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 227,473 | $8.87 M | 39.09% | 0.48% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 220,394 | $8.60 M | -1.00% | 0.46% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 205,500 | $8.01 M | 14.23% | 0.43% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 190,476 | $7.43 M | 0.00% | 0.40% |
| ARDSLEY ADVISORY PARTNERS LP | 11/14/2024 | 190,000 | $7.41 M | 5.56% | 0.40% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 183,344 | $7.15 M | 1,097.78% | 0.38% |
| NEXT CENTURY GROWTH INVESTORS LLC | 11/14/2024 | 164,371 | $6.41 M | 100.00% | 0.34% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 146,411 | $5.71 M | 434.60% | 0.31% |
| NICHOLAS INVESTMENT PARTNERS, LP | 11/12/2024 | 144,479 | $5.63 M | 100.00% | 0.30% |
Mirum Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 204 institutional investors and hedge funds held shares of Mirum Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 6.57 M
JANUS HENDERSON GROUP PLC: 4.48 M
EVENTIDE ASSET MANAGEMENT, LLC: 3.45 M
BlackRock Funding, Inc. /DE: 3.37 M
BVF INC/IL: 3.08 M
VANGUARD GROUP INC: 2.5 M
111.04% of Mirum Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 56.77 M shares in the last 24 months. This purchase volume represents approximately $2.39 B in transactions.